After 6 mo I just had to get a new RX. Unfortuanately, CellCept was not a good option for me, but I had wanted to try so I did for about mos.
I hope this helps and hopefully CellCept will work for you. I do have insurance, but one time I forgot to get my new insurance renewed on time so there was a period of about a month where I didnt have my new insurance. I had to pay for all my medications without insurance and then submit it to the insurance company to be reimbursed.
I hope you get some help from the pharmaceutical company or medicaid because this has been a really great drug for me and can be very helpful, but it is just so pricey. If such contact occurs, wash thoroughly with soap and water; rinse eyes with plain water.
Hypersensitivity reactions to CellCept have been observed see section 4. The risk appears to be related to the intensity and duration of immunosuppression rather than to the use of any specific agent. As general advice to minimise the risk for skin cancer, exposure to sunlight and UV light should be limited by wearing protective clothing and using a sunscreen with a high protection factor.
Infections Patients treated with immunosuppressants, including CellCept, are at increased risk for opportunistic infections bacterial, fungal, viral and protozoal , fatal infections and sepsis see section 4. Such infections include latent viral reactivation, such as hepatitis B or hepatitis C reactivation and infections caused by polyomaviruses BK virus associated nephropathy, JC virus associated progressive multifocal leukoencephalopathy PML.
Cases of hepatitis due to reactivation of hepatitis B or hepatitis C have been reported in carrier patients treated with immunosuppressants. These infections are often related to a high total immunosuppressive burden and may lead to serious or fatal conditions that physicians should consider in the differential diagnosis in immunosuppressed patients with deteriorating renal function or neurological symptoms.
There have been reports of hypogammaglobulinaemia in association with recurrent infections in patients receiving CellCept in combination with other immunosuppressants. In some of these cases switching CellCept to an alternative immunosuppressant resulted in serum IgG levels returning to normal.
Patients on CellCept who develop recurrent infections should have their serum immunoglobulins measured. In cases of sustained, clinically relevant hypogammaglobulinaemia, appropriate clinical action should be considered taking into account the potent cytostatic effects that mycophenolic acid has on T- and B-lymphocytes. There have been published reports of bronchiectasis in adults and children who received CellCept in combination with other immunosuppressants.
In some of these cases switching CellCept to another immunosuppressant resulted in improvement in respiratory symptoms. The risk of bronchiectasis may be linked to hypogammaglobulinaemia or to a direct effect on the lung. There have also been isolated reports of interstitial lung disease and pulmonary fibrosis, some of which were fatal see section 4. It is recommended that patients who develop persistent pulmonary symptoms, such as cough and dyspnoea, are investigated.
Blood and immune system Patients receiving CellCept should be monitored for neutropenia, which may be related to CellCept itself, concomitant medications, viral infections, or some combination of these causes. Patients taking CellCept should have complete blood counts weekly during the first month, twice monthly for the second and third months of treatment, then monthly through the first year. Cases of pure red cell aplasia PRCA have been reported in patients treated with CellCept in combination with other immunosuppressants.
The mechanism for mycophenolate mofetil induced PRCA is unknown. Changes to CellCept therapy should only be undertaken under appropriate supervision in transplant recipients in order to minimise the risk of graft rejection see section 4. Patients receiving CellCept should be instructed to report immediately any evidence of infection, unexpected bruising, bleeding or any other manifestation of bone marrow depression.
Patients should be advised that during treatment with CellCept, vaccinations may be less effective and the use of live attenuated vaccines should be avoided see section 4. Cytomegalovirus CMV , shingles, other herpes infections. CMV can cause serious tissue and blood infections. This virus can damage the kidney. It can cause the new kidney to fail. Hepatitis B and C viruses. Hepatitis viruses can affect how your liver works. Talk to your doctor about how hepatitis viruses may affect you.
Brain infection called progressive multifocal leukoencephalopathy PML. PML can be fatal. Symptoms include clumsiness, weakness that keeps getting worse, not being able to move or use one side of the body, and changes in vision, speech or personality such as not caring about things that you usually care about and confusion.
Yeasts and other types of fungal infections can happen with CellCept and can cause serious tissue and blood infections.
You should not use CellCept if you have ever had an allergic reaction to CellCept or any of its ingredients. Please discuss this with your doctor. People taking high doses of CellCept each day may have a decrease in blood counts, including white blood cells, red blood cells and platelets. Talk to your doctor about the results of all of your pregnancy tests. If you are a woman who can get pregnant, you must use acceptable birth control during your entire CellCept therapy, and continue birth control for 6 weeks after you stop taking CellCept, unless you choose to abstain from sexual intercourse with a man completely.
Talk to your doctor about other birth control methods that you can use while taking CellCept. If you plan to become pregnant, talk with your doctor.
If you become pregnant while taking CellCept, do not stop taking CellCept. Call your doctor right away. In certain situations, you and your doctor may decide that taking CellCept is more important to your health than the possible risks to your unborn baby.
You and your doctor should report your pregnancy to Mycophenolate Pregnancy Registry The purpose of this registry is to gather information about the health of you and your baby. Taking CellCept with other anti-rejection medicines may raise your chance of getting an infection.
It may raise your chance of getting cancer of the immune system lymphoma or other cancers, such as skin cancer. Tell your doctor about any changes in your skin.
CellCept weakens the body's immune system and affects your ability to fight infections. Serious infections, possibly leading to death, can happen with CellCept. These serious infections can include: Certain viruses can live in your body and cause active infections when your immune system is weak. These viruses or infections may include:
© Copyright 2017 Cellcept cost price *** Internet Pharmacy.